View ValuationEcoSynthetix 将来の成長Future 基準チェック /06現在、 EcoSynthetixの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長43.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 06First quarter 2026 earnings released: US$0.01 loss per share (vs US$0.01 loss in 1Q 2025)First quarter 2026 results: US$0.01 loss per share (in line with 1Q 2025). Revenue: US$3.77m (down 6.6% from 1Q 2025). Net loss: US$592.1k (loss narrowed 2.4% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Apr 23EcoSynthetix Inc. to Report Q1, 2026 Results on May 05, 2026EcoSynthetix Inc. announced that they will report Q1, 2026 results at 5:00 PM, US Eastern Standard Time on May 05, 2026お知らせ • Mar 10EcoSynthetix Inc., Annual General Meeting, May 21, 2026EcoSynthetix Inc., Annual General Meeting, May 21, 2026.Reported Earnings • Feb 21Full year 2025 earnings released: US$0.007 loss per share (vs US$0.023 loss in FY 2024)Full year 2025 results: US$0.007 loss per share (improved from US$0.023 loss in FY 2024). Revenue: US$20.8m (up 12% from FY 2024). Net loss: US$433.8k (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.お知らせ • Feb 11EcoSynthetix Inc. to Report Q4, 2025 Results on Feb 19, 2026EcoSynthetix Inc. announced that they will report Q4, 2025 results at 5:00 PM, US Eastern Standard Time on Feb 19, 2026New Risk • Jan 11New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €1.3m This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Significant insider selling over the past 3 months (€1.3m sold).Recent Insider Transactions • Jan 11CEO & Director recently sold €436k worth of stockOn the 7th of January, Jeffrey MacDonald sold around 176k shares on-market at roughly €2.48 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jeffrey has been a net seller over the last 12 months, reducing personal holdings by €180k.New Risk • Dec 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Nov 09Third quarter 2025 earnings released: US$0.002 loss per share (vs US$0.002 profit in 3Q 2024)Third quarter 2025 results: US$0.002 loss per share (down from US$0.002 profit in 3Q 2024). Revenue: US$5.83m (up 12% from 3Q 2024). Net loss: US$91.0k (down 164% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Oct 24EcoSynthetix Inc. to Report Q3, 2025 Results on Nov 06, 2025EcoSynthetix Inc. announced that they will report Q3, 2025 results at 5:00 PM, US Eastern Standard Time on Nov 06, 2025Reported Earnings • Jul 30Second quarter 2025 earnings released: EPS: US$0.002 (vs US$0.012 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.002 (up from US$0.012 loss in 2Q 2024). Revenue: US$5.00m (up 57% from 2Q 2024). Net income: US$111.0k (up US$794.9k from 2Q 2024). Profit margin: 2.2% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • Jul 17EcoSynthetix Inc. to Report Q2, 2025 Results on Jul 29, 2025EcoSynthetix Inc. announced that they will report Q2, 2025 results at 5:00 PM, Eastern Standard Time on Jul 29, 2025Reported Earnings • May 10First quarter 2025 earnings released: US$0.01 loss per share (vs US$0.011 loss in 1Q 2024)First quarter 2025 results: US$0.01 loss per share (improved from US$0.011 loss in 1Q 2024). Revenue: US$4.04m (down 14% from 1Q 2024). Net loss: US$606.5k (loss narrowed 2.1% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.お知らせ • Apr 30EcoSynthetix Inc. to Report Q1, 2025 Results on May 08, 2025EcoSynthetix Inc. announced that they will report Q1, 2025 results at 5:00 PM, US Eastern Standard Time on May 08, 2025お知らせ • Mar 11EcoSynthetix Inc., Annual General Meeting, May 22, 2025EcoSynthetix Inc., Annual General Meeting, May 22, 2025.Reported Earnings • Feb 20Full year 2024 earnings released: US$0.023 loss per share (vs US$0.048 loss in FY 2023)Full year 2024 results: US$0.023 loss per share (improved from US$0.048 loss in FY 2023). Revenue: US$18.5m (up 46% from FY 2023). Net loss: US$1.37m (loss narrowed 52% from FY 2023). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Feb 06EcoSynthetix Inc. to Report Q4, 2024 Results on Feb 19, 2025EcoSynthetix Inc. announced that they will report Q4, 2024 results at 5:00 PM, US Eastern Standard Time on Feb 19, 2025Reported Earnings • Nov 05Third quarter 2024 earnings released: EPS: US$0.002 (vs US$0.005 loss in 3Q 2023)Third quarter 2024 results: EPS: US$0.002 (up from US$0.005 loss in 3Q 2023). Revenue: US$5.23m (up 38% from 3Q 2023). Net income: US$143.2k (up US$411.1k from 3Q 2023). Profit margin: 2.7% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.お知らせ • Oct 23EcoSynthetix Inc. to Report Q3, 2024 Results on Nov 04, 2024EcoSynthetix Inc. announced that they will report Q3, 2024 results at 5:00 PM, US Eastern Standard Time on Nov 04, 2024Board Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Sara Elford was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Jul 31Second quarter 2024 earnings released: US$0.012 loss per share (vs US$0.017 loss in 2Q 2023)Second quarter 2024 results: US$0.012 loss per share (improved from US$0.017 loss in 2Q 2023). Revenue: US$3.18m (up 7.8% from 2Q 2023). Net loss: US$683.9k (loss narrowed 30% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Jul 19EcoSynthetix Inc. to Report Q2, 2024 Results on Jul 30, 2024EcoSynthetix Inc. announced that they will report Q2, 2024 results at 5:00 PM, US Eastern Standard Time on Jul 30, 2024Recent Insider Transactions • May 16Chief Financial Officer recently sold €364k worth of stockOn the 14th of May, Robert Haire sold around 119k shares on-market at roughly €3.05 per share. This transaction amounted to 43% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Robert has been a net seller over the last 12 months, reducing personal holdings by €438k.Reported Earnings • May 07First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.017 loss in 1Q 2023)First quarter 2024 results: US$0.011 loss per share (improved from US$0.017 loss in 1Q 2023). Revenue: US$4.69m (up 53% from 1Q 2023). Net loss: US$619.3k (loss narrowed 37% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.お知らせ • Apr 24EcoSynthetix Inc. to Report Q1, 2024 Results on May 06, 2024EcoSynthetix Inc. announced that they will report Q1, 2024 results at 5:00 PM, US Eastern Standard Time on May 06, 2024お知らせ • Mar 01EcoSynthetix Inc., Annual General Meeting, May 14, 2024EcoSynthetix Inc., Annual General Meeting, May 14, 2024.Reported Earnings • Feb 29Full year 2023 earnings released: US$0.048 loss per share (vs US$0.04 loss in FY 2022)Full year 2023 results: US$0.048 loss per share (further deteriorated from US$0.04 loss in FY 2022). Revenue: US$12.7m (down 34% from FY 2022). Net loss: US$2.82m (loss widened 19% from FY 2022). Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 5% per year.New Risk • Feb 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.8% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).お知らせ • Feb 15EcoSynthetix Inc. to Report Q4, 2023 Results on Feb 27, 2024EcoSynthetix Inc. announced that they will report Q4, 2023 results at 5:00 PM, Eastern Standard Time on Feb 27, 2024Recent Insider Transactions • Nov 18CEO & Director recently sold €231k worth of stockOn the 14th of November, Jeffrey MacDonald sold around 104k shares on-market at roughly €2.22 per share. This transaction amounted to 8.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jeffrey has been a net seller over the last 12 months, reducing personal holdings by €515k.Reported Earnings • Nov 03Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.007 loss in 3Q 2022)Third quarter 2023 results: US$0.005 loss per share (improved from US$0.007 loss in 3Q 2022). Revenue: US$3.80m (down 24% from 3Q 2022). Net loss: US$267.9k (loss narrowed 31% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • Oct 21EcoSynthetix Inc. to Report Q3, 2023 Results on Nov 02, 2023EcoSynthetix Inc. announced that they will report Q3, 2023 results at 5:00 PM, US Eastern Standard Time on Nov 02, 2023New Risk • Aug 04New major risk - Revenue and earnings growthEarnings have declined by 2.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.9% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.3% average weekly change).Reported Earnings • Aug 03Second quarter 2023 earnings released: US$0.017 loss per share (vs US$0.011 loss in 2Q 2022)Second quarter 2023 results: US$0.017 loss per share (further deteriorated from US$0.011 loss in 2Q 2022). Revenue: US$2.95m (down 29% from 2Q 2022). Net loss: US$980.2k (loss widened 45% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.お知らせ • Jul 23EcoSynthetix Inc. to Report Q2, 2023 Results on Aug 02, 2023EcoSynthetix Inc. announced that they will report Q2, 2023 results at 5:00 PM, US Eastern Standard Time on Aug 02, 2023New Risk • Jul 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • May 07First quarter 2023 earnings released: US$0.017 loss per share (vs US$0.011 loss in 1Q 2022)First quarter 2023 results: US$0.017 loss per share (further deteriorated from US$0.011 loss in 1Q 2022). Revenue: US$3.06m (down 28% from 1Q 2022). Net loss: US$988.3k (loss widened 50% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Reported Earnings • Mar 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.055 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (improved from US$0.055 loss in FY 2021). Revenue: US$19.0m (up 4.8% from FY 2021). Net loss: US$2.38m (loss narrowed 25% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.Recent Insider Transactions • Dec 01CEO & Director recently sold €438k worth of stockOn the 25th of November, Jeffrey MacDonald sold around 160k shares on-market at roughly €2.73 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months.Reported Earnings • Nov 04Third quarter 2022 earnings released: US$0.007 loss per share (vs US$0.013 loss in 3Q 2021)Third quarter 2022 results: US$0.007 loss per share (improved from US$0.013 loss in 3Q 2021). Revenue: US$5.02m (up 6.7% from 3Q 2021). Net loss: US$388.9k (loss narrowed 49% from 3Q 2021). Revenue is forecast to grow 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Reported Earnings • Aug 10Second quarter 2022 earnings released: US$0.011 loss per share (vs US$0.013 loss in 2Q 2021)Second quarter 2022 results: US$0.011 loss per share (up from US$0.013 loss in 2Q 2021). Revenue: US$4.17m (down 15% from 2Q 2021). Net loss: US$676.8k (loss narrowed 7.2% from 2Q 2021). Over the next year, revenue is forecast to grow 128%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings.Reported Earnings • May 05First quarter 2022 earnings released: US$0.011 loss per share (vs US$0.013 loss in 1Q 2021)First quarter 2022 results: US$0.011 loss per share (up from US$0.013 loss in 1Q 2021). Revenue: US$4.24m (up 15% from 1Q 2021). Net loss: US$658.9k (loss narrowed 12% from 1Q 2021). Over the next year, revenue is forecast to grow 72%, compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 47% per year, which means it is well ahead of earnings.Reported Earnings • Feb 26Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.055 loss per share (down from US$0.042 loss in FY 2020). Revenue: US$18.2m (up 33% from FY 2020). Net loss: US$3.18m (loss widened 32% from FY 2020). Revenue exceeded analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 46%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 41% per year, which means it is well ahead of earnings.Recent Insider Transactions • Dec 02CEO & Director recently sold €3.1m worth of stockOn the 26th of November, Jeffrey MacDonald sold around 800k shares on-market at roughly €3.86 per share. This was the largest sale by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months.Reported Earnings • Nov 06Third quarter 2021 earnings released: US$0.013 loss per share (vs US$0.011 loss in 3Q 2020)The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$4.71m (up 57% from 3Q 2020). Net loss: US$763.9k (loss widened 19% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 46% per year, which means it is well ahead of earnings.Reported Earnings • Jul 30Second quarter 2021 earnings released: US$0.013 loss per share (vs US$0.011 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$4.90m (up 58% from 2Q 2020). Net loss: US$729.1k (loss widened 20% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.Executive Departure • May 31Independent Director has left the companyOn the 25th of May, Martin Hubbes' tenure as Independent Director ended after 4.4 years in the role. As of March 2021, Martin personally held 164.50k shares (€474k worth at the time). Martin is the only executive to leave the company over the last 12 months.Reported Earnings • May 05First quarter 2021 earnings released: US$0.013 loss per share (vs US$0.008 loss in 1Q 2020)The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$3.67m (down 13% from 1Q 2020). Net loss: US$749.9k (loss widened 68% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Mar 05Full year 2020 earnings released: US$0.042 loss per share (vs US$0.025 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$13.7m (down 26% from FY 2019). Net loss: US$2.40m (loss widened 65% from FY 2019). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Jan 30New 90-day high: €3.12The company is up 85% from its price of €1.69 on 30 October 2020. The German market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 28% over the same period.Is New 90 Day High Low • Jan 14New 90-day high: €2.58The company is up 51% from its price of €1.71 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period.Recent Insider Transactions • Jan 03CFO & Corporate Secretary recently sold €394k worth of stockOn the 31st of December, Robert Haire sold around 169k shares on-market at roughly €2.33 per share. This was the largest sale by an insider in the last 3 months. Robert has been a seller over the last 12 months, reducing personal holdings by €738k.Is New 90 Day High Low • Dec 24New 90-day high: €2.10The company is up 51% from its price of €1.39 on 24 September 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.Recent Insider Transactions • Nov 14CFO & Corporate Secretary recently sold €345k worth of stockOn the 9th of November, Robert Haire sold around 175k shares on-market at roughly €1.97 per share. This was the largest sale by an insider in the last 3 months. This was Robert's only on-market trade for the last 12 months.Is New 90 Day High Low • Nov 11New 90-day high: €1.94The company is up 34% from its price of €1.45 on 12 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period.Reported Earnings • Nov 06Third quarter 2020 earnings released: US$0.011 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: US$2.99m (down 34% from 3Q 2019). Net loss: US$640.7k (loss widened 105% from 3Q 2019).Is New 90 Day High Low • Oct 07New 90-day high: €1.51The company is up 9.0% from its price of €1.39 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、EcoSynthetix は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BST:0Y8 - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202621001N/A12/31/2025210-10N/A9/30/202520-1-1-1N/A6/30/202520-100N/A3/31/202518-1-10N/A12/31/202419-101N/A9/30/202416-2-11N/A6/30/202415-2-20N/A3/31/202414-201N/A12/31/202313-3-10N/A9/30/202315-3-10N/A6/30/202317-3-3-2N/A3/31/202318-3-4-3N/A12/31/202219-2-5-5N/A9/30/202218-3-4-3N/A6/30/202218-3-2-1N/A3/31/202219-3-2-2N/A12/31/202118-300N/A9/30/202117-3-10N/A6/30/202115-3-10N/A3/31/202113-300N/A12/31/202014-200N/A9/30/202015-201N/A6/30/202016-211N/A3/31/202018-211N/A12/31/201918-1N/A1N/A9/30/201920-1N/A1N/A6/30/201921-1N/A0N/A3/31/201922-2N/A0N/A12/31/201823-3N/A-2N/A9/30/201822-4N/A-3N/A6/30/201821-5N/A-3N/A3/31/201820-6N/A-4N/A12/31/201718-6N/A-4N/A9/30/201718-7N/A-5N/A6/30/201716-8N/A-8N/A3/31/201714-9N/A-9N/A12/31/201613-9N/A-8N/A9/30/201612-13N/A-8N/A6/30/201612-13N/A-5N/A3/31/201613-13N/A-6N/A12/31/201515-14N/A-6N/A9/30/201516-12N/A-7N/A6/30/201518-14N/A-11N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0Y8の予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 0Y8の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 0Y8の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 0Y8の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 0Y8の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0Y8の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/11 19:29終値2026/05/08 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋EcoSynthetix Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関James MorrisonATB Cormark Historical (Cormark Securities)Raveel AfzaalCanaccord GenuityIan TharpCIBC Capital Markets3 その他のアナリストを表示
Reported Earnings • May 06First quarter 2026 earnings released: US$0.01 loss per share (vs US$0.01 loss in 1Q 2025)First quarter 2026 results: US$0.01 loss per share (in line with 1Q 2025). Revenue: US$3.77m (down 6.6% from 1Q 2025). Net loss: US$592.1k (loss narrowed 2.4% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Apr 23EcoSynthetix Inc. to Report Q1, 2026 Results on May 05, 2026EcoSynthetix Inc. announced that they will report Q1, 2026 results at 5:00 PM, US Eastern Standard Time on May 05, 2026
お知らせ • Mar 10EcoSynthetix Inc., Annual General Meeting, May 21, 2026EcoSynthetix Inc., Annual General Meeting, May 21, 2026.
Reported Earnings • Feb 21Full year 2025 earnings released: US$0.007 loss per share (vs US$0.023 loss in FY 2024)Full year 2025 results: US$0.007 loss per share (improved from US$0.023 loss in FY 2024). Revenue: US$20.8m (up 12% from FY 2024). Net loss: US$433.8k (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
お知らせ • Feb 11EcoSynthetix Inc. to Report Q4, 2025 Results on Feb 19, 2026EcoSynthetix Inc. announced that they will report Q4, 2025 results at 5:00 PM, US Eastern Standard Time on Feb 19, 2026
New Risk • Jan 11New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €1.3m This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Significant insider selling over the past 3 months (€1.3m sold).
Recent Insider Transactions • Jan 11CEO & Director recently sold €436k worth of stockOn the 7th of January, Jeffrey MacDonald sold around 176k shares on-market at roughly €2.48 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jeffrey has been a net seller over the last 12 months, reducing personal holdings by €180k.
New Risk • Dec 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Nov 09Third quarter 2025 earnings released: US$0.002 loss per share (vs US$0.002 profit in 3Q 2024)Third quarter 2025 results: US$0.002 loss per share (down from US$0.002 profit in 3Q 2024). Revenue: US$5.83m (up 12% from 3Q 2024). Net loss: US$91.0k (down 164% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Oct 24EcoSynthetix Inc. to Report Q3, 2025 Results on Nov 06, 2025EcoSynthetix Inc. announced that they will report Q3, 2025 results at 5:00 PM, US Eastern Standard Time on Nov 06, 2025
Reported Earnings • Jul 30Second quarter 2025 earnings released: EPS: US$0.002 (vs US$0.012 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.002 (up from US$0.012 loss in 2Q 2024). Revenue: US$5.00m (up 57% from 2Q 2024). Net income: US$111.0k (up US$794.9k from 2Q 2024). Profit margin: 2.2% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • Jul 17EcoSynthetix Inc. to Report Q2, 2025 Results on Jul 29, 2025EcoSynthetix Inc. announced that they will report Q2, 2025 results at 5:00 PM, Eastern Standard Time on Jul 29, 2025
Reported Earnings • May 10First quarter 2025 earnings released: US$0.01 loss per share (vs US$0.011 loss in 1Q 2024)First quarter 2025 results: US$0.01 loss per share (improved from US$0.011 loss in 1Q 2024). Revenue: US$4.04m (down 14% from 1Q 2024). Net loss: US$606.5k (loss narrowed 2.1% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
お知らせ • Apr 30EcoSynthetix Inc. to Report Q1, 2025 Results on May 08, 2025EcoSynthetix Inc. announced that they will report Q1, 2025 results at 5:00 PM, US Eastern Standard Time on May 08, 2025
お知らせ • Mar 11EcoSynthetix Inc., Annual General Meeting, May 22, 2025EcoSynthetix Inc., Annual General Meeting, May 22, 2025.
Reported Earnings • Feb 20Full year 2024 earnings released: US$0.023 loss per share (vs US$0.048 loss in FY 2023)Full year 2024 results: US$0.023 loss per share (improved from US$0.048 loss in FY 2023). Revenue: US$18.5m (up 46% from FY 2023). Net loss: US$1.37m (loss narrowed 52% from FY 2023). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Feb 06EcoSynthetix Inc. to Report Q4, 2024 Results on Feb 19, 2025EcoSynthetix Inc. announced that they will report Q4, 2024 results at 5:00 PM, US Eastern Standard Time on Feb 19, 2025
Reported Earnings • Nov 05Third quarter 2024 earnings released: EPS: US$0.002 (vs US$0.005 loss in 3Q 2023)Third quarter 2024 results: EPS: US$0.002 (up from US$0.005 loss in 3Q 2023). Revenue: US$5.23m (up 38% from 3Q 2023). Net income: US$143.2k (up US$411.1k from 3Q 2023). Profit margin: 2.7% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
お知らせ • Oct 23EcoSynthetix Inc. to Report Q3, 2024 Results on Nov 04, 2024EcoSynthetix Inc. announced that they will report Q3, 2024 results at 5:00 PM, US Eastern Standard Time on Nov 04, 2024
Board Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Sara Elford was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jul 31Second quarter 2024 earnings released: US$0.012 loss per share (vs US$0.017 loss in 2Q 2023)Second quarter 2024 results: US$0.012 loss per share (improved from US$0.017 loss in 2Q 2023). Revenue: US$3.18m (up 7.8% from 2Q 2023). Net loss: US$683.9k (loss narrowed 30% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Jul 19EcoSynthetix Inc. to Report Q2, 2024 Results on Jul 30, 2024EcoSynthetix Inc. announced that they will report Q2, 2024 results at 5:00 PM, US Eastern Standard Time on Jul 30, 2024
Recent Insider Transactions • May 16Chief Financial Officer recently sold €364k worth of stockOn the 14th of May, Robert Haire sold around 119k shares on-market at roughly €3.05 per share. This transaction amounted to 43% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Robert has been a net seller over the last 12 months, reducing personal holdings by €438k.
Reported Earnings • May 07First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.017 loss in 1Q 2023)First quarter 2024 results: US$0.011 loss per share (improved from US$0.017 loss in 1Q 2023). Revenue: US$4.69m (up 53% from 1Q 2023). Net loss: US$619.3k (loss narrowed 37% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
お知らせ • Apr 24EcoSynthetix Inc. to Report Q1, 2024 Results on May 06, 2024EcoSynthetix Inc. announced that they will report Q1, 2024 results at 5:00 PM, US Eastern Standard Time on May 06, 2024
お知らせ • Mar 01EcoSynthetix Inc., Annual General Meeting, May 14, 2024EcoSynthetix Inc., Annual General Meeting, May 14, 2024.
Reported Earnings • Feb 29Full year 2023 earnings released: US$0.048 loss per share (vs US$0.04 loss in FY 2022)Full year 2023 results: US$0.048 loss per share (further deteriorated from US$0.04 loss in FY 2022). Revenue: US$12.7m (down 34% from FY 2022). Net loss: US$2.82m (loss widened 19% from FY 2022). Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 5% per year.
New Risk • Feb 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.8% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).
お知らせ • Feb 15EcoSynthetix Inc. to Report Q4, 2023 Results on Feb 27, 2024EcoSynthetix Inc. announced that they will report Q4, 2023 results at 5:00 PM, Eastern Standard Time on Feb 27, 2024
Recent Insider Transactions • Nov 18CEO & Director recently sold €231k worth of stockOn the 14th of November, Jeffrey MacDonald sold around 104k shares on-market at roughly €2.22 per share. This transaction amounted to 8.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jeffrey has been a net seller over the last 12 months, reducing personal holdings by €515k.
Reported Earnings • Nov 03Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.007 loss in 3Q 2022)Third quarter 2023 results: US$0.005 loss per share (improved from US$0.007 loss in 3Q 2022). Revenue: US$3.80m (down 24% from 3Q 2022). Net loss: US$267.9k (loss narrowed 31% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • Oct 21EcoSynthetix Inc. to Report Q3, 2023 Results on Nov 02, 2023EcoSynthetix Inc. announced that they will report Q3, 2023 results at 5:00 PM, US Eastern Standard Time on Nov 02, 2023
New Risk • Aug 04New major risk - Revenue and earnings growthEarnings have declined by 2.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.9% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.3% average weekly change).
Reported Earnings • Aug 03Second quarter 2023 earnings released: US$0.017 loss per share (vs US$0.011 loss in 2Q 2022)Second quarter 2023 results: US$0.017 loss per share (further deteriorated from US$0.011 loss in 2Q 2022). Revenue: US$2.95m (down 29% from 2Q 2022). Net loss: US$980.2k (loss widened 45% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
お知らせ • Jul 23EcoSynthetix Inc. to Report Q2, 2023 Results on Aug 02, 2023EcoSynthetix Inc. announced that they will report Q2, 2023 results at 5:00 PM, US Eastern Standard Time on Aug 02, 2023
New Risk • Jul 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • May 07First quarter 2023 earnings released: US$0.017 loss per share (vs US$0.011 loss in 1Q 2022)First quarter 2023 results: US$0.017 loss per share (further deteriorated from US$0.011 loss in 1Q 2022). Revenue: US$3.06m (down 28% from 1Q 2022). Net loss: US$988.3k (loss widened 50% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.055 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (improved from US$0.055 loss in FY 2021). Revenue: US$19.0m (up 4.8% from FY 2021). Net loss: US$2.38m (loss narrowed 25% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Dec 01CEO & Director recently sold €438k worth of stockOn the 25th of November, Jeffrey MacDonald sold around 160k shares on-market at roughly €2.73 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months.
Reported Earnings • Nov 04Third quarter 2022 earnings released: US$0.007 loss per share (vs US$0.013 loss in 3Q 2021)Third quarter 2022 results: US$0.007 loss per share (improved from US$0.013 loss in 3Q 2021). Revenue: US$5.02m (up 6.7% from 3Q 2021). Net loss: US$388.9k (loss narrowed 49% from 3Q 2021). Revenue is forecast to grow 54% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 10Second quarter 2022 earnings released: US$0.011 loss per share (vs US$0.013 loss in 2Q 2021)Second quarter 2022 results: US$0.011 loss per share (up from US$0.013 loss in 2Q 2021). Revenue: US$4.17m (down 15% from 2Q 2021). Net loss: US$676.8k (loss narrowed 7.2% from 2Q 2021). Over the next year, revenue is forecast to grow 128%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings.
Reported Earnings • May 05First quarter 2022 earnings released: US$0.011 loss per share (vs US$0.013 loss in 1Q 2021)First quarter 2022 results: US$0.011 loss per share (up from US$0.013 loss in 1Q 2021). Revenue: US$4.24m (up 15% from 1Q 2021). Net loss: US$658.9k (loss narrowed 12% from 1Q 2021). Over the next year, revenue is forecast to grow 72%, compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 47% per year, which means it is well ahead of earnings.
Reported Earnings • Feb 26Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.055 loss per share (down from US$0.042 loss in FY 2020). Revenue: US$18.2m (up 33% from FY 2020). Net loss: US$3.18m (loss widened 32% from FY 2020). Revenue exceeded analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 46%, compared to a 6.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 41% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Dec 02CEO & Director recently sold €3.1m worth of stockOn the 26th of November, Jeffrey MacDonald sold around 800k shares on-market at roughly €3.86 per share. This was the largest sale by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months.
Reported Earnings • Nov 06Third quarter 2021 earnings released: US$0.013 loss per share (vs US$0.011 loss in 3Q 2020)The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$4.71m (up 57% from 3Q 2020). Net loss: US$763.9k (loss widened 19% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 46% per year, which means it is well ahead of earnings.
Reported Earnings • Jul 30Second quarter 2021 earnings released: US$0.013 loss per share (vs US$0.011 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$4.90m (up 58% from 2Q 2020). Net loss: US$729.1k (loss widened 20% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
Executive Departure • May 31Independent Director has left the companyOn the 25th of May, Martin Hubbes' tenure as Independent Director ended after 4.4 years in the role. As of March 2021, Martin personally held 164.50k shares (€474k worth at the time). Martin is the only executive to leave the company over the last 12 months.
Reported Earnings • May 05First quarter 2021 earnings released: US$0.013 loss per share (vs US$0.008 loss in 1Q 2020)The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$3.67m (down 13% from 1Q 2020). Net loss: US$749.9k (loss widened 68% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 05Full year 2020 earnings released: US$0.042 loss per share (vs US$0.025 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$13.7m (down 26% from FY 2019). Net loss: US$2.40m (loss widened 65% from FY 2019). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Jan 30New 90-day high: €3.12The company is up 85% from its price of €1.69 on 30 October 2020. The German market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 28% over the same period.
Is New 90 Day High Low • Jan 14New 90-day high: €2.58The company is up 51% from its price of €1.71 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period.
Recent Insider Transactions • Jan 03CFO & Corporate Secretary recently sold €394k worth of stockOn the 31st of December, Robert Haire sold around 169k shares on-market at roughly €2.33 per share. This was the largest sale by an insider in the last 3 months. Robert has been a seller over the last 12 months, reducing personal holdings by €738k.
Is New 90 Day High Low • Dec 24New 90-day high: €2.10The company is up 51% from its price of €1.39 on 24 September 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.
Recent Insider Transactions • Nov 14CFO & Corporate Secretary recently sold €345k worth of stockOn the 9th of November, Robert Haire sold around 175k shares on-market at roughly €1.97 per share. This was the largest sale by an insider in the last 3 months. This was Robert's only on-market trade for the last 12 months.
Is New 90 Day High Low • Nov 11New 90-day high: €1.94The company is up 34% from its price of €1.45 on 12 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period.
Reported Earnings • Nov 06Third quarter 2020 earnings released: US$0.011 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: US$2.99m (down 34% from 3Q 2019). Net loss: US$640.7k (loss widened 105% from 3Q 2019).
Is New 90 Day High Low • Oct 07New 90-day high: €1.51The company is up 9.0% from its price of €1.39 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.